Peter Villax

Non-executive Partner

Peter Villax is a Partner at Biovance Capital. Peter has over 40 years of experience in the pharmaceutical industry in IT, sales, R&D and business administration. He joined Hovione in 1982 as a computer programmer and led Hovione’s computerization. He then switched to pharmaceutical development in 1990 and soon became interested in pulmonary delivery. His disposable dry-powder inhaler TwinCaps, licensed to Daiichi Sankyo for the delivery of Influenza drug Inavir®, continues to be the only commercial device of its kind in the world, and has helped Daiichi Sankyo become the market leader in influenza products in Japan. He acquired significant experience as an inventor of devices, as a patentholder and as a licensor of technology patents. Peter founded Bionova Capital in 2015, having been its CEO from 2015 to 2019. In 2019, he became the Chairman of Bionova Capital. Peter is the President of the Portuguese Family Business Association and Board member of civic and academic bodies.